Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 1 Chronic Hepatitis C”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01221298
What this trial is testing

A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-072 and Ribavirin (RBV)

Who this might be right for
Hepatitis CHCVChronic Hepatitis C Infection+1 more
AbbVie (prior sponsor, Abbott) 11
Large-scale testing (Phase 3)Study completedNCT03219216
What this trial is testing

Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults in Brazil With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 100
Not applicableStudy completedNCT00926016
What this trial is testing

Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects

Who this might be right for
Chronic Hepatitis C
Brooke Army Medical Center 23
Early research (Phase 1)Study completedNCT01247194
What this trial is testing

A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1

Who this might be right for
Chronic Genotype 1 Hepatitis C Virus Infection
Presidio Pharmaceuticals, Inc. 24
Large-scale testing (Phase 3)Study completedNCT01701401
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 870
Testing effectiveness (Phase 2)Study completedNCT01054729
What this trial is testing

Dose-Ranging Study of Sofosbuvir in Combination With Pegylated Interferon and Ribavirin in Treatment Naïve GT 1 HCV Patients

Who this might be right for
Hepatitis C
Gilead Sciences 64
Not applicableStudy completedNCT04189627
What this trial is testing

The Effectiveness and Clinical Practice Use of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Genotypes 1 to 6 in Russian Federation

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 99
Large-scale testing (Phase 3)Study completedNCT01939197
What this trial is testing

A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection

Who this might be right for
Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more
AbbVie 318
Large-scale testing (Phase 3)Study completedNCT01573351
What this trial is testing

Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials)

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 398
Testing effectiveness (Phase 2)Study completedNCT00475176
What this trial is testing

S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 24
Large-scale testing (Phase 3)Study completedNCT00703118
What this trial is testing

A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment

Who this might be right for
Hepatitis C, Chronic
Tibotec BVBA 663
Testing effectiveness (Phase 2)Study completedNCT01726517
What this trial is testing

Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 100
Not applicableStudy completedNCT02669940
What this trial is testing

Observational, Multi-Center Study of the Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian Federation

Who this might be right for
Chronic Hepatitis CGenotype 1
AbbVie 158
Post-approval studies (Phase 4)Study completedNCT01447420
What this trial is testing

Sustained Virological Response in Relation to IL28-b Expression in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1 on Combination Treatment With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 129
Testing effectiveness (Phase 2)Study completedNCT01132313
What this trial is testing

Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 488
Early research (Phase 1)Study completedNCT01185860
What this trial is testing

Ritonavir-Boosted Danoprevir (RO5190591) in Combination With Pegasys and Ribavirin in Patients With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 59
Testing effectiveness (Phase 2)Study completedNCT00377182
What this trial is testing

Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS With or Without COPEGUS in Patients With Chronic Hepatitis C (CHC) Genotype 1 Infection.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 107
Large-scale testing (Phase 3)Ended earlyNCT00662220
What this trial is testing

High-dose Ribavirin in Treatment of Chronic Hepatitis C Genotype 1 or 4

Who this might be right for
Chronic Hepatitis C
Foundation for Liver Research 110
Large-scale testing (Phase 3)Study completedNCT00237484
What this trial is testing

Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM4)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 89
Not applicableStudy completedNCT03868163
What this trial is testing

Real World Evidence of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C in the Russian Federation

Who this might be right for
Chronic Hepatitis C (CHC)
AbbVie 161
Next Page